Intraindividual stability of human erythrocyte cholinesterase activity

Clinical Chemistry

Volumn 53, Issue 7, 2007, Pages 1358-1363

  Lefkowitz, Lee J ^a,c   Kupina, Joseph M ^a   Hirth, Nigel L ^a   Henry, Rachel M ^a   Noland, Georgia Y ^b   Barbee Jr , John Y ^b   Zhou, Joey Y ^a   Weese, Coleen B ^a  

^a U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

^b US Army Occupational Health Clinic   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; NERVE GAS; ORGANOPHOSPHORUS COMPOUND; PESTICIDE;

ADULT; ARTICLE; ASSAY; CHEMICAL INDUSTRY; CHEMICAL WARFARE; CHOLINESTERASE INHIBITION; CLINICAL ARTICLE; EMPLOYMENT; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; INDUSTRIAL WORKER; MALE; OCCUPATIONAL EXPOSURE; RETROSPECTIVE STUDY;

BIOLOGICAL MARKERS; CHEMICAL INDUSTRY; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; ERYTHROCYTES; HUMANS; LINEAR MODELS; MALE; OCCUPATIONAL EXPOSURE; ORGANOPHOSPHORUS COMPOUNDS; REFERENCE VALUES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 34347387952     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.085258     Document Type: Article

References (28)

1. Department of the Army. Occupational Health Guidelines for the Evaluation and Control of Occupational Exposure to Nerve Agents GA, GB, and VX. Pamphlet 40-8. Washington, DC: Headquarters, Department of the Army, 1990:14pp.
2. Ngai W, Ames RG, Wisniewski J, Fan AM. Guidelines for Physicians Who Supervise Workers Exposed to Cholinesterase-lnhibiting Pesticides, 4th ed. Oakland, CA: Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, 2002.
3. Wilson BW, Henderson JD, Arrieta DE, O'Malley MA. Meeting requirements of the California cholinesterase monitoring program. Int J Toxicol 2004;23:97-100.
4. Limperos G, Ranta KE. A rapid screening test for the determination of the approximate cholinesterase activity of human blood. Science 1953;117:453-5.
5. Rider JA, Hodges JL, Swader J, Wiggins AD. Plasma and red blood cell cholinesterase in 800 healthy donors. J Lab Clin Med 1957; 50:376-83.
6. Department of the Army. Red Blood Cell-Cholinesterase Testing and Quality Assurance. Technical Bulletin Medical 590. Washington, DC: Headquarters, Department of the Army, 2001:15pp.
7. Sidell FR, Kaminskis A. Influence of age, sex, and oral contraceptives on human blood cholinesterase activity. Clin Chem 1975; 21:1393-5.
8. Allison AC, Burn GP. Enzyme activity as a function of age in the human erythrocyte. Br J Haematol 1955;1:291-303.
9. Gage JC. The significance of blood cholinesterase activity measurements. Residue Rev 1966;18:159-73.
10. Sawitsky A, Fitch HM, Meyer LM. A study of cholinesterase activity in the blood of normal subjects. J Lab Clin Med 1948;33:203-6.
11. Callaway S, Davies DR, Rutland JP. Blood cholinesterase levels and range of personal variation in a healthy adult population. Br Med J 1951;2:812-6.
12. Augustinsson K-B. The normal variation of human blood cholinesterase activity. Acta Physiol Scand 1955;35:40-52.
13. Sabine JC. The clinical significance of erythrocyte cholinesterase titers. I. A method suitable for routine clinical use, and the distribution of normal values. Blood 1955;10:1132-8.
14. Shanor SP, Van Hees GR, Baart N, Erdos EG, Foldes FF. The influence of age and sex on human plasma and red cell cholinesterase. Am J Med Sci 1961;357-61.
15. Sidell FR, Kaminskis A. Temporal intrapersonal physiological variability of cholinesterase activity in human plasma and erythrocytes. Clin Chem 1975;21:1961-3.
16. Ellin RI, Burkhardt BH, Hart RD. A time-modified method for measuring red blood cell cholinesterase activity. Arch Environ Health 1973;27:48-9.
17. Michel HO. An electrometric method for the determination of red blood cell and plasma cholinesterase activity. J Lab Clin Med 1949;34:1564-8.
18. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
19. Groff WA, Kaminskis A, Ellin RI. Interconversion of cholinesterase enzyme activity units by the manual delta pH method and a recommended automated method. Clin Toxicol 1976;9:353-8.
20. Harris EK. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974;20:1535-42.
21. Petersen PH, Sandberg S, Fraser CG, Goldschmidt H. Influence of index of individuality on false positives in repeated sampling from healthy individuals. Clin Chem Lab Med 2001;39:160-5.
22. Harris EK, Yasaka T. On the calculation of a "reference change" for comparing two consecutive measurements. Clin Chem 1983; 29:25-30.
23. Ricos C, Cava F, Garcia-Lario JV, Hernandez A, Iglesias N, Jimenez CV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004;64:175-84.
24. Petersen PH, Fraser CG, Sandberg S, Goldschmidt H. The index of individuality is often a misinterpreted quantity characteristic. Clin Chem Lab Med 1999;37:655-61.
25. Coye MJ, Lowe JA, Maddy KT. Biological monitoring of agricultural workers exposed to pesticides. I. Cholinesterase activity determinations. J Occup Med 1986;28:619-27.
26. Lotti M. Cholinesterase inhibition: complexities in interpretation. Clin Chem 1995;41:1814-8.
27. Wilson BW, Padilla S, Henderson JD, Brimijoin S, Dass PD, Elliot G, et al. Factors in standardizing automated cholinesterase assays. J Toxicol Environ Health 1996;48:187-95.
28. Wilson BW, Henderson JD, Ramirez A, O'Malley MA. Standardization of clinical cholinesterase measurements. Int J Toxicol 2002; 21:385-8.